Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT04339452

Impella Supported OPCABG

Impella-supported Off-pump Coronary Artery Bypass Grafting in High Risk Revascularizations: a Single Center Prospective Observational Study

Status
Active Not Recruiting
Phase
Study type
Observational
Enrollment
30 (estimated)
Sponsor
Lucian Archambault Durham III · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The present study introduces a novel approach to coronary revascularization through the use of a short term minimally-invasive left ventricular assist device (LVAD) to minimize myocardial injury and eliminate low output state during the perioperative period

Conditions

Interventions

TypeNameDescription
DEVICEImpella 5.5 with SmartAssist Supported OPCABGSubjects will undergo insertion of an axillary or ascending aortic Impella 5.5 with SmartAssist, followed by Impella-supported OPCABG using a sternotomy approach with shunting of the coronary arteries to achieve myocardial protection.

Timeline

Start date
2022-05-11
Primary completion
2025-12-01
Completion
2026-03-01
First posted
2020-04-09
Last updated
2025-01-27

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT04339452. Inclusion in this directory is not an endorsement.

Impella Supported OPCABG (NCT04339452) · Clinical Trials Directory